National Center for Preparedness, Detection, and Control of Infectious Diseases, 46299 [E8-18285]
Download as PDF
Federal Register / Vol. 73, No. 154 / Friday, August 8, 2008 / Notices
Dated: July 24, 2008.
Penelope Slade Royall,
RADM, USPHS, Deputy Assistant Secretary
for Health, (Disease Prevention and Health
Promotion).
[FR Doc. E8–18299 Filed 8–7–08; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Preparedness,
Detection, and Control of Infectious
Diseases
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting.
pwalker on PROD1PC71 with NOTICES
Name: Clinical Laboratory Improvement
Advisory Committee (CLIAC).
Times and Dates: 8:30 a.m.–5 p.m.,
September 10, 2008; 8:30 a.m.–3 p.m.,
September 11, 2008.
Place: Centers for Disease Control and
Prevention, 1600 Clifton Road, NE., Tom
Harkin Global Communications Center,
Building 19, Room 232, Auditorium B,
Atlanta, Georgia 30333.
New Information—Online Registration
Required: In order to expedite security
clearance process at the CDC Roybal Campus
located on Clifton Road, all CLIAC attendees
are required to register in advance for the
meeting at https://www.cdc.gov/cliac/
default.aspx by clicking the Register for a
‘‘Meeting’’ link and completing all forms
according to the instructions given. Please
complete all the required fields and submit
your registration as far in advance of the
meeting date as possible.
Note: The cut-off date for registration for
domestic attendees is Thursday, September
4, 2008; the cut-off date for international
attendees to register is Monday, August 25,
2008.
Status: Open to the public, limited only by
the space available. The meeting Room
accommodates approximately 100 people.
Purpose: This Committee is charged with
providing scientific and technical advice and
guidance to the Secretary of Health and
Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the
need for, and the nature of, revisions to the
standards under which clinical laboratories
are regulated; the impact on medical and
laboratory practice of proposed revisions to
the standards; and the modification of the
standards to accommodate technological
advances.
Matters to Be Discussed: The agenda will
include updates from the CDC, the Centers
for Medicare & Medicaid Services, and the
Food and Drug Administration; a report from
the CLIAC Workgroup on Good Laboratory
Practices for Genetic Testing, and discussion
VerDate Aug<31>2005
17:25 Aug 07, 2008
Jkt 214001
of the Workgroup’s proposals related to such;
presentations and discussion related to
laboratory quality control through risk
management; and an introduction to the
status of waived testing and discussion of the
potential for waiver of automated hematology
devices. Agenda items are subject to change
as priorities dictate.
Providing Oral or Written Comments: It is
the policy of CLIAC to accept written public
comments and provide a brief period for oral
public comments whenever possible.
Oral Comments: In general, each
individual or group requesting to make an
oral presentation will be limited to a total
time of five minutes (unless otherwise
indicated). Speakers must also submit their
comments in writing for inclusion in the
meeting’s Summary Report. To assure
adequate time is scheduled for public
comments, individuals or groups planning to
make an oral presentation should, when
possible, notify the contact person below at
least one week prior to the meeting date.
Written Comments: For individuals or
groups unable to attend the meeting, CLIAC
accepts written comments until the date of
the meeting (unless otherwise stated).
However, the comments should be received
at least one week prior to the meeting date
so that the comments may be made available
to the Committee for their consideration and
public distribution. Written comments, one
hard copy with original signature, should be
provided to the contact person below.
Written comments will be included in the
meeting’s Summary Report.
Contact Person for Additional Information:
Nancy Anderson, Chief, Laboratory Practice
Standards Branch, Division of Laboratory
Systems, National Center for Preparedness,
Detection, and Control of Infectious Diseases,
Coordinating Center for Infectious Diseases,
CDC, 1600 Clifton Road, NE., Mailstop F–11,
Atlanta, Georgia 30333; telephone (404) 498–
2741; fax (404) 498–2219; or via e-mail at
Nancy.Anderson@cdc.hhs.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
CDC and the Agency for Toxic Substances
and Disease Registry.
Dated: July 28, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–18285 Filed 8–7–08; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
46299
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff;
Modifications to the International
Classification of Diseases, Ninth
Revision, Clinical Modification (ICD–9–
CM), Supplementary Classification of
External Causes of Injury and
Poisoning
ACTION:
Notice.
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff, announces
the following modifications to the
International Classification of Diseases,
Ninth Revision, Clinical Modification
(ICD–9–CM), Supplementary
Classification of External Causes of
Injury and Poisoning. These codes will
become effective October 1, 2008.
External Cause Tabular
New code E927.0 Overexertion from
sudden strenuous movement. Sudden
trauma from strenuous movement
New code E927.1 Overexertion from
prolonged static position
New code E927.2 Excessive physical
exertion from prolonged activity
New code E927.3 Cumulative trauma
from repetitive motion
New code E927.4 Cumulative trauma
from repetitive impact
New code E927.8 Other overexertion
and strenuous and repetitive
movements or loads
New code E927.9 Unspecified
overexertion and strenuous and
repetitive movements or loads
CONTACT PERSON FOR ADDITIONAL
INFORMATION: Donna Pickett, Medical
Systems Specialist, Classifications and
Public Health Data Standards Staff,
NCHS, 3311 Toledo Road, Room 2402,
Hyattsville, Maryland 20782, e-mail
dfp4@cdc.gov, telephone 301–458–4434.
The complete diagnosis addenda may be
accessed on the NCHS Web site using
the URL: https://www.cdc.gov/nchs/
datawh/ftpserv/ftpicd9/
ftpicd9.htm#addenda.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to modifications to
the ICD–9–CM, for both CDC and the
E:\FR\FM\08AUN1.SGM
08AUN1
Agencies
[Federal Register Volume 73, Number 154 (Friday, August 8, 2008)]
[Notices]
[Page 46299]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-18285]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Preparedness, Detection, and Control of
Infectious Diseases
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting.
Name: Clinical Laboratory Improvement Advisory Committee
(CLIAC).
Times and Dates: 8:30 a.m.-5 p.m., September 10, 2008; 8:30
a.m.-3 p.m., September 11, 2008.
Place: Centers for Disease Control and Prevention, 1600 Clifton
Road, NE., Tom Harkin Global Communications Center, Building 19,
Room 232, Auditorium B, Atlanta, Georgia 30333.
New Information--Online Registration Required: In order to
expedite security clearance process at the CDC Roybal Campus located
on Clifton Road, all CLIAC attendees are required to register in
advance for the meeting at https://www.cdc.gov/cliac/default.aspx by
clicking the Register for a ``Meeting'' link and completing all
forms according to the instructions given. Please complete all the
required fields and submit your registration as far in advance of
the meeting date as possible.
Note: The cut-off date for registration for domestic attendees
is Thursday, September 4, 2008; the cut-off date for international
attendees to register is Monday, August 25, 2008.
Status: Open to the public, limited only by the space available.
The meeting Room accommodates approximately 100 people.
Purpose: This Committee is charged with providing scientific and
technical advice and guidance to the Secretary of Health and Human
Services, the Assistant Secretary for Health, and the Director, CDC,
regarding the need for, and the nature of, revisions to the
standards under which clinical laboratories are regulated; the
impact on medical and laboratory practice of proposed revisions to
the standards; and the modification of the standards to accommodate
technological advances.
Matters to Be Discussed: The agenda will include updates from
the CDC, the Centers for Medicare & Medicaid Services, and the Food
and Drug Administration; a report from the CLIAC Workgroup on Good
Laboratory Practices for Genetic Testing, and discussion of the
Workgroup's proposals related to such; presentations and discussion
related to laboratory quality control through risk management; and
an introduction to the status of waived testing and discussion of
the potential for waiver of automated hematology devices. Agenda
items are subject to change as priorities dictate.
Providing Oral or Written Comments: It is the policy of CLIAC to
accept written public comments and provide a brief period for oral
public comments whenever possible.
Oral Comments: In general, each individual or group requesting
to make an oral presentation will be limited to a total time of five
minutes (unless otherwise indicated). Speakers must also submit
their comments in writing for inclusion in the meeting's Summary
Report. To assure adequate time is scheduled for public comments,
individuals or groups planning to make an oral presentation should,
when possible, notify the contact person below at least one week
prior to the meeting date.
Written Comments: For individuals or groups unable to attend the
meeting, CLIAC accepts written comments until the date of the
meeting (unless otherwise stated). However, the comments should be
received at least one week prior to the meeting date so that the
comments may be made available to the Committee for their
consideration and public distribution. Written comments, one hard
copy with original signature, should be provided to the contact
person below. Written comments will be included in the meeting's
Summary Report.
Contact Person for Additional Information: Nancy Anderson,
Chief, Laboratory Practice Standards Branch, Division of Laboratory
Systems, National Center for Preparedness, Detection, and Control of
Infectious Diseases, Coordinating Center for Infectious Diseases,
CDC, 1600 Clifton Road, NE., Mailstop F-11, Atlanta, Georgia 30333;
telephone (404) 498-2741; fax (404) 498-2219; or via e-mail at
Nancy.Anderson@cdc.hhs.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for CDC and the Agency for Toxic Substances and Disease
Registry.
Dated: July 28, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-18285 Filed 8-7-08; 8:45 am]
BILLING CODE 4163-18-P